QUINOXALINE COMPOUNDS AS TYPE III RECEPTOR TYROSINE KINASE INHIBITORS

• 收藏
• 分享

专利权人:

Development Center for Biotechnology

发明人:

Shao-Zheng Peng,Chu-Bin Liao,Hung-Kai Chen,Chen-Hsuan Ho,Hung-Jyun Huang,Shian-Yi Chiou

申请号：

US16340685

公开号：

US20190308949A1

申请日:

2017.10.09

申请国别(地区):

US

年份:

2019

代理人:

摘要：

A compound, capable of inhibiting kinases, for the treatments of diseases or disorders mediated by such kinases, has a structure of formula (I):or a stereoisomer, a tautomer, a pharmaceutically acceptable salt thereof. The compound can be used in the treatments of diseases or conditions mediated by CSF-1R, c-KIT, FLT3, or PDGFR kinases. Such diseases or conditions may include cancers, autoimmune diseases, and bone resorptive diseases.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/